Gene-Environment Interactions in Schizophrenia: A Literature Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gene-Environment Interactions in Schizophrenia: A Literature Review
Authors
Keywords
-
Journal
Genes
Volume 12, Issue 12, Pages 1850
Publisher
MDPI AG
Online
2021-11-24
DOI
10.3390/genes12121850
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complement C4 associations with altered microbial biomarkers exemplify gene-by-environment interactions in schizophrenia
- (2021) Emily G. Severance et al. SCHIZOPHRENIA RESEARCH
- Polygenic risk scores differentiate schizophrenia patients with toxoplasma gondii compared to toxoplasma seronegative patients
- (2021) Adriana Lori et al. COMPREHENSIVE PSYCHIATRY
- Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank
- (2021) Michael Wainberg et al. Translational Psychiatry
- COVID-19 patient transcriptomic and genomic profiling reveals comorbidity interactions with psychiatric disorders
- (2021) Mohammad Ali Moni et al. Translational Psychiatry
- Maternal immune activation and neuroinflammation in human neurodevelopmental disorders
- (2021) Velda X. Han et al. Nature Reviews Neurology
- Environmental Risk Factors for Schizophrenia and Bipolar Disorder and Their Relationship to Genetic Risk: Current Knowledge and Future Directions
- (2021) Natassia Robinson et al. Frontiers in Genetics
- Polygenic liability for schizophrenia and childhood adversity influences daily‐life emotion dysregulation and psychosis proneness
- (2020) L.‐K. Pries et al. ACTA PSYCHIATRICA SCANDINAVICA
- Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
- (2020) Jerome Sarris et al. BMC Psychiatry
- Relationship between Toxoplasma gondii seropositivity and schizophrenia in the Lebanese population: potential implication of genetic polymorphism of MMP-9
- (2020) Amata El Mouhawass et al. BMC Psychiatry
- Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?
- (2020) Chandni Hindocha et al. Translational Psychiatry
- The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging”
- (2020) Gholam Hossein Meftahi et al. INFLAMMATION RESEARCH
- Association of Recent Stressful Life Events With Mental and Physical Health in the Context of Genomic and Exposomic Liability for Schizophrenia
- (2020) Lotta-Katrin Pries et al. JAMA Psychiatry
- The COVID-19 Cytokine Storm; What We Know So Far
- (2020) Dina Ragab et al. Frontiers in Immunology
- Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses
- (2020) Debanjan Banerjee et al. Asian Journal of Psychiatry
- The association between exposure to herpes simplex virus type 1 (HSV-1) and cognitive functioning in schizophrenia: A meta-analysis
- (2020) Faith Dickerson et al. PSYCHIATRY RESEARCH
- Additive effect of glutathione S-transferase T1 active genotype and infection with Toxoplasma gondii for increasing the risk of schizophrenia
- (2020) Maryam Ansari-Lari et al. NORDIC JOURNAL OF PSYCHIATRY
- Predictive Performance of Exposome Score for Schizophrenia in the General Population
- (2020) Lotta-Katrin Pries et al. SCHIZOPHRENIA BULLETIN
- How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
- (2019) Eva Hoch et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis
- (2019) Miquel Bioque et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study
- (2019) Sinan Guloksuz et al. World Psychiatry
- Genome-wide association study in two populations to determine genetic variants associated with Toxoplasma gondii infection and relationship to schizophrenia risk
- (2019) Alex W. Wang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Non-Genetic Factors in Schizophrenia
- (2019) Simona A. Stilo et al. Current Psychiatry Reports
- Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence
- (2018) Marieke Hiemstra et al. DRUG AND ALCOHOL DEPENDENCE
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Polygenic risk for schizophrenia and season of birth within the UK Biobank cohort
- (2018) Valentina Escott-Price et al. PSYCHOLOGICAL MEDICINE
- Gene–environment interplay in the etiology of psychosis
- (2018) Alyson Zwicker et al. PSYCHOLOGICAL MEDICINE
- The Exposome Paradigm and the Complexities of Environmental Research in Psychiatry
- (2018) Sinan Guloksuz et al. JAMA Psychiatry
- The Complexities of Evaluating the Exposome in Psychiatry: A Data-Driven Illustration of Challenges and Some Propositions for Amendments
- (2018) Sinan Guloksuz et al. SCHIZOPHRENIA BULLETIN
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Brain changes in a maternal immune activation model of neurodevelopmental brain disorders
- (2018) Lara Bergdolt et al. PROGRESS IN NEUROBIOLOGY
- Maternal immune activation, central nervous system development and behavioral phenotypes
- (2018) Elena Minakova et al. Birth Defects Research
- Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review
- (2017) Błażej Misiak et al. MOLECULAR NEUROBIOLOGY
- Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood
- (2017) N Dedic et al. MOLECULAR PSYCHIATRY
- Cannabis use and risk of schizophrenia: a Mendelian randomization study
- (2017) J Vaucher et al. MOLECULAR PSYCHIATRY
- Cannabis-associated psychosis: Neural substrate and clinical impact
- (2017) R.M. Murray et al. NEUROPHARMACOLOGY
- The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data
- (2017) Eduardo S. Gouvêa et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Stress-Dependent Association Between Polygenic Risk for Schizophrenia and Schizotypal Traits in Young Army Recruits
- (2017) Alex Hatzimanolis et al. SCHIZOPHRENIA BULLETIN
- The emerging role of the FKBP5 gene polymorphisms in vulnerability–stress model of schizophrenia: further evidence from a Serbian population
- (2016) Marina Mihaljevic et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Immunoglobulin G genotypes and the risk of schizophrenia
- (2016) Janardan P. Pandey et al. HUMAN GENETICS
- Beyond the association.Toxoplasma gondiiin schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis
- (2015) A. L. Sutterland et al. ACTA PSYCHIATRICA SCANDINAVICA
- Psychosocial versus physiological stress — Meta-analyses on deactivations and activations of the neural correlates of stress reactions
- (2015) Lydia Kogler et al. NEUROIMAGE
- Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis
- (2015) Marco Colizzi et al. SCHIZOPHRENIA BULLETIN
- Early Cannabis Use, Polygenic Risk Score for Schizophrenia and Brain Maturation in Adolescence
- (2015) Leon French et al. JAMA Psychiatry
- Infection and Inflammation in Schizophrenia and Bipolar Disorder: A Genome Wide Study for Interactions with Genetic Variation
- (2015) Dimitrios Avramopoulos et al. PLoS One
- Genetic predisposition to schizophrenia associated with increased use of cannabis
- (2014) R A Power et al. MOLECULAR PSYCHIATRY
- Loss-of-Function Variants in Schizophrenia Risk and SETD1A as a Candidate Susceptibility Gene
- (2014) Atsushi Takata et al. NEURON
- Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci
- (2013) A D Børglum et al. MOLECULAR PSYCHIATRY
- Using summary data from the Danish National Registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder
- (2013) Naomi Wray Frontiers in Genetics
- Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users
- (2012) Marta Di Forti et al. BIOLOGICAL PSYCHIATRY
- Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: A putative model of gene×environment interaction
- (2012) Lieve Desbonnet et al. BRAIN BEHAVIOR AND IMMUNITY
- Les facteurs de risque environnementaux de la schizophrénie
- (2012) J. Vilain et al. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE
- Evaluation of HLA Polymorphisms in Relation to Schizophrenia Risk and Infectious Exposure
- (2012) Mikhil Bamne et al. SCHIZOPHRENIA BULLETIN
- Exposure to Herpes Simplex Virus Type 1 and Cognitive Impairments in Individuals With Schizophrenia
- (2012) K. M. Prasad et al. SCHIZOPHRENIA BULLETIN
- Childhood infection and adult schizophrenia: A meta-analysis of population-based studies
- (2012) Golam M. Khandaker et al. SCHIZOPHRENIA RESEARCH
- C-reactive protein is elevated in schizophrenia
- (2012) Faith Dickerson et al. SCHIZOPHRENIA RESEARCH
- Association of GRIN1 and GRIN2A-D With schizophrenia and genetic interaction with maternal herpes simplex virus-2 infection affecting disease risk
- (2011) Ditte Demontis et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder
- (2011) Ruud van Winkel et al. NEUROPSYCHOPHARMACOLOGY
- Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia
- (2011) Beng-Choon Ho et al. SCHIZOPHRENIA RESEARCH
- Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
- (2010) Alan S. Brown et al. AMERICAN JOURNAL OF PSYCHIATRY
- COMT Val158Met-Stress Interaction in Psychosis: Role of Background Psychosis Risk
- (2010) Dina Collip et al. CNS Neuroscience & Therapeutics
- Brain Cannabinoid CB2 Receptor in Schizophrenia
- (2009) Hiroki Ishiguro et al. BIOLOGICAL PSYCHIATRY
- Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study
- (2009) Paul Lichtenstein et al. LANCET
- Longitudinal Study of Stressful Life Events and Daily Stressors Among Adolescents at High Risk for Psychotic Disorders
- (2009) K. D. Tessner et al. SCHIZOPHRENIA BULLETIN
- Researching Genetic Versus Nongenetic Determinants of Disease: A Comparison and Proposed Unification
- (2009) J. P. A. Ioannidis et al. Science Translational Medicine
- Are some cases of psychosis caused by microbial agents? A review of the evidence
- (2008) R H Yolken et al. MOLECULAR PSYCHIATRY
- Gene-Environment Interplay Between Cannabis and Psychosis
- (2008) C. Henquet et al. SCHIZOPHRENIA BULLETIN
- Psychosocial Stress and Psychosis. A Review of the Neurobiological Mechanisms and the Evidence for Gene-Stress Interaction
- (2008) R. van Winkel et al. SCHIZOPHRENIA BULLETIN
- Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
- (2008) T. Walsh et al. SCIENCE
- Comprehensive evaluation of positional candidates in the IL-18 pathway reveals suggestive associations with schizophrenia and herpes virus seropositivity
- (2007) Brian H. Shirts et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Evidence that the COMTVal158Met polymorphism moderates sensitivity to stress in psychosis: An experience-sampling study
- (2007) Ruud van Winkel et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia
- (2007) Nora Hamdani et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation